-
Loading metrics
Contribution of EGFR and ErbB-3 Heterodimerization to the EGFR Mutation-Induced Gefitinib- and Erlotinib-Resistance in Non-Small-Cell Lung Carcinoma Treatments
- Debby D. Wang,
- Lichun Ma,
- Maria P. Wong,
- Victor H. F. Lee,
- Hong Yan
x
- Published: May 20, 2015
- https://doi.org/10.1371/journal.pone.0128360